Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) — CLL17

Chronic Lymphoid Leukemia Clinical Trial

Official title:
A Phase 3 Multicentre, Randomized, Prospective, Open-label Trial of Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Status Active, not recruiting

Clinical Trial Summary

The aim of this study is to compare the efficacy of continuous ibrutinib monotherapy with fixed-duration venetoclax plus obinutuzumab and fixed-duration ibrutinib plus venetoclax by measuring progression-free survival (PFS) in patients with previously untreated CLL.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Chronic Lymphoid Leukemia
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid

Clinical Trial Details

NCT number	NCT04608318
Study type	Interventional
Source	German CLL Study Group
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	March 1, 2021
Completion date	March 2027

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04515238` - Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL	Phase 2
Completed	`NCT00406809` - A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies	Phase 1/Phase 2
Recruiting	`NCT03766763` - Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A	Phase 2
Active, not recruiting	`NCT04883749` - Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL	Phase 2
Recruiting	`NCT03804372` - The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide	Phase 2
Active, not recruiting	`NCT00788684` - Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers	Phase 1
Terminated	`NCT01518959` - The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases	Phase 3
Completed	`NCT03787264` - Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL	Phase 2
Recruiting	`NCT03852407` - Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning	Phase 2
Recruiting	`NCT05350826` - Evaluation of the Ambulatory Medical Assistance Nurse Program in Chronic Lymphocytic Leukemia	N/A